Substantial advances have been made in the adjuvant management of patients
with resectable rectal cancer. Increasing interest in patient quality of li
fe has promoted the use of radiation therapy to enhance sphincter-preservin
g surgical approaches as an alternative to the standard abdominoperineal re
section. Because of the suggestion of enhanced sphincter preservation with
preoperative therapy and the potential advantage of decreased acute morbidi
ty, randomized trials comparing preoperative and postoperative adjuvant com
bined modality therapy are ongoing. Recent progress in adjuvant postoperati
ve treatment regimens relates to the integration of systemic therapy to rad
iation, and redefining the techniques for both modalities. The incorporatio
n of improved radiation planning may reduce treatment-related bower toxicit
y. The integration of novel chemotherapeutic agents in the adjuvant therapy
of rectal cancer remains an active area of investigation. (C) 2001 Lippinc
ott Williams & Wilkins. Inc.